Myacyne (Neomycin Sulfate)

Neomycin Sulfate, the active ingredient in Myacyne, is an aminoglycoside antibiotic presented as a topical formulation for cutaneous use. It treats superficial bacterial skin infections and helps prevent infection in minor cuts, abrasions, and burns, providing a localized antibacterial effect.

GNH USA supplies Myacyne as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Myacyne, a topical aminoglycoside antibiotic, is used for conditions involving superficial bacterial skin involvement.

- Superficial bacterial skin infections: reduces bacterial load and promotes healing. - Minor cuts, abrasions, and burns: prevents secondary bacterial infection. - Post‑procedural skin sites: provides prophylactic antibacterial coverage.

Adverse reactions are generally limited to the site of application, but systemic effects can occur rarely.

Common Side Effects: - Local skin irritation: redness or mild discomfort at the application site. - Itching: transient pruritus where the product is applied. - Mild burning sensation: brief sensation during or after application.

Serious or Rare Side Effects: - Allergic contact dermatitis: severe rash, swelling, or blistering requiring medical attention. - Systemic toxicity: rare systemic absorption leading to nephrotoxicity or ototoxicity. - Anaphylaxis: extremely rare, life‑threatening hypersensitivity reaction.

Use Myacyne with attention to known sensitivities and proper application techniques.

- Allergy assessment: avoid if known hypersensitivity to neomycin or other aminoglycosides. - Pregnancy: use only if the potential benefit justifies the potential risk; data are limited. - Breastfeeding: caution advised, although systemic absorption is minimal. - Application area: limit to small, uncomplicated skin areas; avoid extensive or occluded surfaces. - Duration of use: discontinue if irritation persists beyond 7 days or worsens. - Store at room temperature: keep in the original container, protect from moisture and light.

Neomycin Sulfate may interact with other agents that affect renal function or auditory health, as well as with products that alter its local activity.

Major Interactions (Avoid): - Concurrent systemic aminoglycosides: increased risk of ototoxicity. - Nephrotoxic agents (e.g., vancomycin, amphotericin B): potential additive renal toxicity. - Use of other topical neomycin products: risk of cumulative overdose.

Moderate Interactions (Monitor Closely): - Topical corticosteroids: may mask signs of local irritation. - Metal‑ion containing dressings: can reduce antibacterial efficacy. - Systemic antibiotics: monitor for cross‑resistance patterns.